A pharmaceutical study on different approaches for itopride hydrochloride sustainment: In-vitro and in-vivo evaluation

被引:0
|
作者
机构
[1] Yehia, Soad A.
[2] El Shafeey, Ahmed H.
[3] El Meshad, Aliaa
[4] Al-Bialey, Hamoud A.
来源
Yehia, S. A. | 1600年 / Journal of Chemical and Pharmaceutical Research, 3/668 Malviya Nagar, Jaipur, Rajasthan, India卷 / 04期
关键词
Drug products - Drug dosage - Controlled drug delivery - Biochemistry - Granulation - Targeted drug delivery - Blending - Cellulose - Plastic coatings;
D O I
暂无
中图分类号
学科分类号
摘要
Recent trends indicate that dosage form drug delivery systems are especially suitable for achieving sustained or delayed release oral formulations with low risk of dose dumping, flexibility of blending to attain different release patterns as well as reproducibility. One of the approaches toward this goal was to develop and formulate extended release matrix oral tablets of itopride hydrochloride (ITO) as a highly water soluble drug and to increase its gastric retention time. Matrix tablets of (ITO) were developed using different methods such as: (wetting granulation, direct compression, and coating compression), by using different types of polymers (hydroxypropyl methyl cellulose (HPMC) K15M, hydroxypropyl cellulose (HPC) low viscosity, Eudragit&reg RL100, and Carnauba wax). The prepared tablets were evaluated according to various physicochemical characteristics such as: weight and thickness variation, drug content, hardness, friability, and in vitro drug release. Tablet weight variation ranged from 395 ± 0.34 to 409 ± 1.78 mg, thickness ranged from 3.16 ± 1.37 to 3.74 mm, drug content ranged from 94.5 ± 1.01% to 106.2 ± 0.08%, friability ranged from 0.04 ± 0.69 to 0.84 ± 0.45, and hardness ranged from 5.25 ± 0.25 to 8.80 ± 0.4 Kg/cm2. Results indicated that drug release depended upon method of preparation and polymer type. Furthermore, in vivo testing of the optimum sustained release tablet formulation (F23) using coating compression by HPMC as coat was performed in human subjects, and determined and compared to that of a commercial oral tablet (Ganaton&reg) as a reference formulation. The obtained the maximum plasma concentration (Cmax) and the area under the curve from zero to infinity (AUC (0-∞) values were higher following formulated tablet administration than after Ganaton&reg administration. The percentage relative bioavailability of ITO from the selected formula in human volunteers was found to be 243% compared to Ganaton&reg.
引用
收藏
相关论文
共 50 条
  • [1] A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation
    Moqbel, Helal Abdo
    ElMeshad, Aliaa Nabil
    El-Nabarawi, Mohamed Ahmed
    DRUG DELIVERY, 2016, 23 (08) : 2998 - 3007
  • [2] Development and in Vitro/In Vivo Evaluation of Itopride Hydrochloride Expanding Tablets
    Ahmed, Walaa
    El-Gogary, Riham I.
    Nasr, Maha
    Sammour, Omaima A.
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2023, 18 (03) : 1350 - 1361
  • [3] Development and in Vitro/In Vivo Evaluation of Itopride Hydrochloride Expanding Tablets
    Walaa Ahmed
    Riham I. El-Gogary
    Maha Nasr
    Omaima A. Sammour
    Journal of Pharmaceutical Innovation, 2023, 18 : 1350 - 1361
  • [4] Radiopacity evaluation of different glass ionomer cements: an in-vitro and in-vivo study
    Antunes Santos, Ana M.
    Goncalves, Flavia
    Borges Albanesi, Rafael
    Sandoval, Mario S.
    Procida Raggio, Daniela
    Volpi Mello-Moura, Anna C.
    CHIRURGIA-ITALY, 2019, 32 (06): : 306 - 312
  • [5] Promising nanoparticulate system for topical delivery of diphenhydramine hydrochloride: In-vitro and in-vivo evaluation
    Aziz, Sandy N.
    Badawy, Alia A.
    Nessem, Demiana, I
    Abd El Malak, Nevine S.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2020, 55
  • [6] FORMULATION, IN-VITRO AND IN-VIVO EVALUATION OF SUSTAINED-RELEASE MEBEVERINE HYDROCHLORIDE MICROSPHERES
    BAYOMI, MA
    KHIDR, SH
    ABDELHADY, SS
    ALANGARY, AA
    PHARMAZEUTISCHE INDUSTRIE, 1994, 56 (02): : 192 - 194
  • [7] IN-VIVO AND IN-VITRO EVALUATION OF A BIOMACHINABLE GLASSCERAMIC
    RATHINAM, K
    SIVAKUMAR, R
    SARASWATI, V
    BULLETIN OF MATERIALS SCIENCE, 1994, 17 (02) : 171 - 179
  • [8] IN-VITRO, IN-VIVO EVALUATION OF PHENFORMIN FORMULATIONS
    SIMMONS, DL
    LEGORE, AA
    KLAPKA, M
    JOSHI, NN
    CANADIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 8 (04): : 139 - 141
  • [9] IN-VIVO AND IN-VITRO EVALUATION OF LIQUID ANTACIDS
    FORDTRAN, JS
    MORAWSKI, SG
    RICHARDSON, CT
    NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (18): : 923 - 928
  • [10] GENE-THERAPY FOR HIV-1 INFECTION - IN-VITRO AND IN-VIVO EVALUATION OF DIFFERENT COMPLEMENTARY APPROACHES
    CALENDA, V
    LEISSNER, P
    SORG, T
    LEROY, P
    MARIGLIANO, M
    TOURAINE, JL
    SANHADJI, K
    PAVIRANI, A
    MEHTALI, M
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S166 - S166